CHOO CHEE KONG sold 24.1% of their position (200K shares) of CYTOMED THERAPEUTICS LTD on the open market
Open‑market sale worth $300.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/24/2026ACC: 0001493152-26-034516
Director10% Owner
Since Mar 2023
-200K
Net shares
Net seller
$300.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
200K disposed
Non-Derivative Transactions2
ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED
Direct
Shares
−100K
Price / share
$1.50
Trade value
$150K
% of position
15.9%
7/14/2026
630.32K→530.32K
ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED
Direct
Shares
−100K
Price / share
$1.50
Trade value
$150K
% of position
13.7%
7/20/2026
730.32K→630.32K
Total
Net shares
−200K
Net value
-$300K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED Direct | 7/14/2026 | P · Purchase | −100K | $1.50 | $150K | 15.9% | 630.32K | 530.32K |
| ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED Direct | 7/20/2026 | P · Purchase | −100K | $1.50 | $150K | 13.7% | 730.32K | 630.32K |
| Total | −200K | -$300K | ||||||
Derivative Transactions0
No derivative transactions reported